from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1586c/-

LFCtreatmentdescriptionclass of inhibitor

-0.502

Amikacinug/mL Amikacintranslation

-0.691

Cap5-10ug/mL Capreomycintranslation

-0.922

Rox10-50 ug/mL Roxithromycintranslation

0.545

SM2-5 ug/mL Streptomycintranslation

-0.443

Tet5-10 ug/mL Tetracyclinetranslation

-0.683

Rif0.2-5ug/mL Rifampicintranscription

-0.758

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.095

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.290

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.065

CPZ10-50 ug/mL Chlorpromazinerespiration

0.193

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.281

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

4.273

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.585

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.215

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.181

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.024

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.359

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.756

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.917

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.607

KCN5-20 ug/mL Potassium cyaniderespiration

-0.753

NaN30.2-2 mM Sodium aziderespiration

0.968

Nigericin50 uM Nigericinrespiration

0.664

TRC10-150 ug/mL Triclosanrespiration

1.422

TRZ10-25 ug/mL Thioridazinerespiration

2.513

Valinomycin0.5-10 uM Valinomycinrespiration

0.625

ZnSO42 mM ZnSO4respiration

1.161

menadione6-10 ug/mL Menadionerespiration

-0.529

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.644

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.409

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.305

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.138

NRP_1Non-replicating persistence stage 1dosRassociated

-0.363

Amp0.2mg/mL AmpicillincellWall

-0.242

Cephalexin20-100 ug/mL CephalexincellWall

-0.272

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.582

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.324

EMB10-20 ug/mL EthambutolcellWall

-0.281

Eta12-40 ug/mL EthionamidecellWall

-0.323

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.279

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.299

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.468

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.487

BZA0.12 mg/mL BenzamidearomaticAmides

0.314

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.714

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.197

H2O24 mM hydrogen peroxideDNAdamaging

-0.011

Levo10 ug/mL LevofloxacinDNAdamaging

-0.450

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.783

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.104

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.423

UVUV-irradiationDNAdamaging

3.538

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.361

Antimycin12.5-50 ug/mL Antimycin A?

-0.476

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.519

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.261

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.624

PA8240.2-2 ug/mL PA-824?

0.345

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.356

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.344

Verapamil50 uM Verapamil?

-0.426

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.475

methoxatin10-20 ug/mL Methoxatin?